scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences
BURLINGTON, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that John Tucker, President and Chief Executive Officer, will participate in the following upcoming investor conferences:
- The Citizens Life Sciences Conference: Presentation on Wednesday, May 7 at 9:30 a.m. ET.
- Craig-Hallum 22nd Annual Institutional Investor Conference: Wednesday, May 28, Investor Meetings Only
- H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ: Presentation on May 20 at 10:00 a.m. ET.
A webcast of the presentations can be accessed or under “News & Events” in the Investor Relations section of the Company’s website, .
About scPharmaceuticals
At scPharmaceuticals, we are powered by passion, driven by patient care. Our Mission is focused on advancing cardiorenal care through innovative, integrated treatments that address unmet patient needs.
Our goal is to become the foremost advocate for patient-centric cardiorenal care, driving global health improvements through specialized, multidisciplinary approaches. scPharmaceuticals is expanding its reach, offering integrated therapies and products that address diverse healthcare needs and potentially improve the lives of our patients. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit .
Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
Investors:
Nick Colangelo
Gilmartin Group, 339-225-1047
